Growth with an exhausting slope
Adwya’s sales decreased by 1.7% in June, 2015, pulled down by the branded products because of GSK's supply problems. In fact, the revenues of the branded products dropped from TND25.6M in H1 2014 to TND24.5M in H1 2015. However, this decline was reduced from 12.5% in Q1 2015 to 4.3% in H1 2015, confirming the recovery of GSK's line of products. Generics displayed a modest growth rate of 3.4%, contributing 35% to sales, vs.
AlphaMena is the MENA stocks leader in independent equity research, covering 142. MENA securities spanning across 19 sectors and 8 countries relaying on a team of 11 analysts. The breadth of coverage allows AlphaMena to formulate a coherent view on markets, sectors and to highlight the best investments in Mena zone using a robust homogeneous and transparent methodology, enabling pure and pertinent comparisons based on financial and extra-financial criteria.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.